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Uremic autonomic neuropathy studied by spectral analysis of quelae, but the pathogenesis is unknown [1–3]. It has
heart rate. been demonstrated that parasympathetic neuropathy,
Background. There is good evidence that power spectral caused mostly by afferent lesions, appears more fre-analysis (PSA) of heart rate variability may provide an insight
quently than sympathetic damage, being isolated in 14into the understanding of autonomic disorders.
to 34% of patients and combined with a damage of bloodMethods. We investigated 30 chronic uremic patients who were
on periodic bicarbonate hemodialysis by a battery of six cardio- pressure control in 18 to 24% of subjects [3–6]. The
vascular autonomic tests (beat-to-beat variations during quiet presence and severity of autonomic neuropathy (AN)
breathing and deep breathing, heart rate responses to the Val- do not seem to be related with either the duration ofsalva maneuver and standing, blood pressure responses to stand-
renal failure or with the duration of dialysis. In recenting and sustained handgrip) and PSA of heart rate variations.
years, there has been an increased interest in the litera-Results. Eleven patients (37%) had an abnormal response
to only one parasympathetic test. Twelve patients (40%) had ture about autonomic nervous system function in chronic
a definite parasympathetic damage, as indicated by at least two uremia, especially in the pathogenic investigations of
abnormal heart rate tests, whereas four (13%) had combined
two important complications: hypertension and suddenparasympathetic and sympathetic damage. Multivariate analy-
cardiac death [7, 8].sis of the cardiovascular tests revealed that 19 patients (63%)
had moderate-to-severe autonomic neuropathy (AN), and 11 The few longitudinal studies that exist failed to show
patients exhibited normal autonomic function. Among the symp- that long-term dialysis has a beneficial effect on AN
toms suggestive of autonomic dysfunction, only impotence in [9–11], which led us to speculate that uremic autonomicmales was significantly associated with test-proven AN. The
damage is somewhat irreversible. However, when thePSA of the heart rate variability demonstrated a good discrimi-
effects of kidney transplantation were investigated, thenation of low-frequency (LF) and high-frequency (HF) bands
(LF, 0.03 to 0.15 Hz; HF, 0.15 to 0.33 Hz) among controls, results were contradictory. Agarwal et al have reported
uremic patients without test-proven AN, and uremic patients a slight improvement of some autonomic indices six
with test-proven AN. A significant reduction of the LF value
months following renal transplantation [10]. In diabeticon supine uremic patients without AN suggests that an early
nephropathy, AN has been found to be unchanged upsympathetic involvement exists that traditional autonomic tests
were unable to detect. to four years after simultaneous transplantation of kid-
Conclusions. Our study indicates that the current opinion ney and pancreas [12, 13]. It is noteworthy that the Swed-
of a major parasympathetic damage in chronic uremic patients ish Huddinge group, despite a clear improvement ofon hemodialysis has to be modified in favor of a more wide-
somatic polyneuropathy, found no significant change ofspread autonomic dysfunction involving both the sympathetic
AN at 6 and 12 months after renal transplantation, asand parasympathetic pathways.
well as 6, 12, and 24 months after combined kidney-
pancreas transplantation [14, 15]. However, they docu-
Involvement of the autonomic nervous system may oc- mented a slight improvement of parasympathetic func-
cur in patients with chronic renal failure who are on peri- tion 48 months either following kidney graft or after
odic hemodialysis. It may have a number of clinical se- combined transplantation [16]. The latter findings sug-
gested that uremic AN needs a long time to be repaired
in transplanted patients. A recent study from our groupKey words: uremia, hemodialysis, cardiovascular tests, autonomic neu-
ropathy, power spectral analysis. was in good accordance with recent transplantation in-
vestigations, showing that AN can recover after long-Received for publication July 15, 1998
term (8 years) bicarbonate dialysis [17].and in revised form February 1, 1999
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dominantly parasympathetic or sympathetic function, has been detailed elsewhere [19, 20]. Briefly, a normal
model was computed by a pattern-recognition method,such as active standing, deep breathing, Valsalva maneu-
ver, and sustained handgrip test [18]. A multivariate ap- the Bayesian analysis, using seven variables, that is, the
six test results and age, from 85 sex- and age-matchedproach by a pattern recognition analysis has been dem-
onstrated to increase the diagnostic efficiency of the tests normal subjects. The distance from the normal model
centroid (Mahalanobis distance) was measured in each[19, 20]. Although these tests are very helpful in routine
clinical practice and most studies are based on them, patient. Because of a probability transformation, a con-
fidence level was estimated in the range 0 to 100. A levelthey have been criticized as being of little use in the
investigation of the sympathetic pathway. Several studies of 95 or higher indicated the presence of autonomic
damage.have provided evidence that specific heart rate spectral
components may reflect autonomic cardiovascular in- The second phase of the study included the investiga-
tion of power spectral analysis (PSA) of heart rate varia-fluences [21–24]. This report describes the use of spectral
analysis of heart rate variability in the evaluation of tions. After each subject had a 10-minute rest, a surface
electrocardiogram from a thoracic lead taken while theuremic AN.
subject was resting in the supine position was obtained
for 10 minutes. The subject was then moved to a standing
METHODS
position (0 → 858) by a tilting table, and again, after at
Thirty chronic uremic patients, aged 19 to 85 years least four minutes of stabilization, the heart rate was
(mean 6 sd, 58 6 14 years; 22 men and 8 women), were measured for another 10-minute period. Twenty normal
studied. They were on periodic bicarbonate hemodialysis subjects aged 22 to 75 years (mean 6 sd, 56 6 15 years;
(4 hr for 3 times per week) for periods ranging from 1 12 men and 8 women) served as controls. A dedicated
month to 22 years. None of them had heart failure, severe software program (SEDICO-HS srl) recognized the indi-
hypertension, ischemic heart disease, diabetes mellitus, vidual electrocardiographic R wave and the correspond-
bronchopneumopathy, or amyloidosis, nor were they ing R-R intervals. The PSA of a sequence of 500 R-R
taking medications known to affect the autonomic ner- intervals was estimated by the autoregressive modeling
vous system. Thirteen patients had mild-to-moderate hy- technique, providing a low-frequency (LF) band in the
pertension and were on therapy with nifedipine, doxazo- range of 0.03 to 0.15 Hz, and a high-frequency (HF)
sin, or angiotensin-converting enzyme inhibitors. Anemia band in the range of 0.15 to 0.33 Hz. LF and HF compo-
was treated with folic acid, vitamins, iron, and erythro- nents are regarded, but not invariably, as specific markers
poietin. After informed consent had been obtained, they of sympathetic and parasympathetic activities, respec-
were requested to refrain from smoking and coffee for tively [22].
at least 12 hours before the investigation, which was
performed at 10:00 a.m. or 4:00 p.m. in a dialysis-free Statistics
day of the middle week. They were also asked to have The PSA values are expressed as mean 6 sem. Statisti-
a light breakfast and lunch. cal comparisons of results were made using Student’s t-
In the beginning of the examination, a questionnaire test. Fisher’s test was used to evaluate differences in the
was administered for symptoms suggestive of autonomic presence of symptoms suggestive of autonomic dysfunc-
dysfunction. The investigation of autonomic function tion. The relationship between variables was studied us-
was performed in two phases. In the first one, a battery ing linear regression analysis. A value of P , 0.05 was
of cardiovascular autonomic tests was accomplished as considered significant.
previously described [25]. The four tests of predomi-
nantly parasympathetic function were beat-to-beat varia-
RESULTStions during quiet breathing and deep breathing and
heart rate responses to Valsalva maneuver and to stand- The questionnaire revealed that all patients referred
to at least one of the symptoms suggestive of AN. Theing. The two tests of predominantly sympathetic function
were blood pressure responses to standing and to sus- most frequent findings were impotence in males (73%),
bowel dysfunction with diarrhea and/or constipationtained handgrip. Finapres (Ohmeda spa, Milan, Italy) was
used for continuous noninvasive blood pressure record- (63%), bladder problems (63%), and gastroparesis
(60%; Table 1). Pseudomotor problems and orthostaticings. A dedicated software program for the automatic
evaluation of the tests (SEDICO-HS srl, Padua, Italy) intolerance were less frequent (43 and 37%, respec-
tively). Furthermore, 12 patients (40%) suffered fromwas used. Normal, borderline, and abnormal values for
each test have been detailed in earlier studies [11, 25]. hemodialysis-induced hypotension.
Three patients (10%) had normal responses to all car-The test results were also evaluated by multivariate
analysis, which has been demonstrated to be a valuable diovascular autonomic tests. Eleven patients (37%) had
an abnormal response to only one parasympathetic test;method to investigate uremic AN [11, 17]; the procedure
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Table 1. Symptoms of autonomic dysfunction in 30 chronic uremic patients
Number of patients
Total (%) without AN with AN Significance
Impotence 16/22M (73) 3 13 P , 0.05
Bowel dysfunction 19 (63) 9 10 NS
Bladder problems 19 (63) 5 14 NS
Gastric fullness or delay in emptying 18 (60) 7 11 NS
Sudomotor problems 13 (43) 7 6 NS
Orthostatic intolerance 11 (37) 4 7 NS
Hemodialysis-induced hypotension 12 (40) 5 7 NS
Abbreviations are: AN, autonomic neuropathy; NS, not significant.
12 patients (40%) showed a definite parasympathetic mean power values obtained during the time they were
damage, as indicated by at least two abnormal heart rate supine were not significantly different among controls,
tests, whereas 4 (13%) had combined parasympathetic uremic patients without AN (90 6 27), and uremic pa-
and sympathetic damage. tients with AN (106 6 29).
Multivariate analysis of the six cardiovascular auto- While standing, the LF mean power value in uremic
nomic tests revealed that 19 patients (63%) had moder- subjects without AN was 231 6 90, which was not differ-
ate-to-severe AN [confidence interval (CI) ranging from ent from that of the control subjects (Fig. 2B). The value
97 to 100], and 11 patients exhibited normal autonomic obtained in uremic patients with AN (89 6 29) was
function (CI 35 to 87). The CI as an index of autonomic significantly lower from that of controls (P , 0.003). The
status was not correlated with either age or the duration HF mean power values during standing were 61 6 20 in
of dialysis. Among symptoms of autonomic dysfunction, uremic patients without AN (no difference with controls)
only impotence resulted as being significantly (P , 0.05) and 19 6 11 in uremic patients with AN, a value that
associated with test-proven AN (Table 1). Moreover, was significantly lower from controls (P , 0.02) and
autonomic dysfunction was unrelated to the presence of from that of uremic patients without AN (P , 0.05).
hypertension or hemodialysis-induced hypotension. The LF/HF ratio value results were 5.0 6 1.7 in uremic
The LF mean power value in chronic uremics who patients without AN and 5.8 6 2.3 in uremic patients with
were supine was 152 6 34, which was significantly lower AN when they were supine (Fig. 2C). While standing, the
from that of control subjects (415 6 82, P , 0.0002; Fig. corresponding values were 14.4 6 9 and 23 6 9.7. There
1A). The HF mean power value result was not signifi- were no significant differences among controls and both
cantly different between uremic patients (100 6 21) and subgroups of uremic patients.
controls (165 6 4). The total variance and spectral components normal-
While standing, the LF mean power value in chronic ized by total variance are shown in Table 2. The total
uremic patients was 141 6 39, which was significantly variance was significantly lower in uremic patients than
lower from that of control subjects (316 6 132, P , 0.02; controls, without any difference between the two sub-
Fig. 1B). Again, the HF mean power value was not differ- groups of patients. Only the LF power value during
ent between uremics (34 6 5) and controls (56 6 47). standing resulted in significantly lower values in the total
The LF/HF ratio values resulted on lying 6.5 6 3.4 in uremic patients’ group and in uremic patients with AN
controls and 5.5 6 1.6 in uremics and on standing 9.9 6 group than in normal controls.
2.6 in controls and 19.9 6 6.8 in uremics, with no signifi-
cant differences (Fig. 1C). PSA values did not vary as
DISCUSSIONfunction of uremic patients’ age or duration of dialysis,
Although traditional autonomic tests still remain theexcept for the LF mean power value on standing, which
cornerstone in the clinical approach to patients with au-correlated with age (r 5 20.502, P , 0.01).
tonomic dysfunction, the PSA of heart rate variabilityWhen the group of uremics were divided into two
may add useful information to the natural history of ANsubgroups according to the results of traditional cardio-
in a number of conditions, providing a more accuratevascular tests, the LF mean power value in 11 uremics
evaluation of cardiovascular autonomic activity [23, 24].without AN who were supine was 202 6 66, which was
As an example, traditional autonomic tests led to thesignificantly lower from that of the control subjects (P ,
erroneous interpretation that diabetic AN began with0.04; Fig. 2A). The results obtained in 19 uremic patients
an early parasympathetic failure that was only later fol-with AN were 123 6 37, a value not different from
lowed by sympathetic impairment. On the basis of PSA,that of the uremic patients without AN, but significantly
different from that of controls (P , 0.0003). The HF that opinion has been totally revised in favor of a more
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Fig. 2. Low- and high-frequency power spectrum density components
(respectively, LF and HF) during supine (A) and standing (B) positions
in 20 control subjects (h), 11 uremic patients without test-proven AN
( ), and 19 uremic patients with test-proven AN (j). The LF/HF ratio
is illustrated in (C). The results are expressed as mean 6 sem; the
statistical significance of differences is listed above the bars.
Fig. 1. Low- and high-frequency power spectrum density components
(respectively, LF and HF) during lying (A) and standing (B) in 20 control
subjects (h) and 30 uremic patients (j) on periodic hemodialysis. The
Only a very few studies have investigated the spectralLF/HF ratio is illustrated in (C). The results are expressed as mean 6
sem; *P , 0.0002; **P , 0.02. analysis of heart rate variability in small numbers of
patients with chronic renal failure, with no or little com-
parison with the traditional autonomic tests. Axelrod et
al have studied 8 patients treated by hemodialysis, 7 on
widespread autonomic failure that simultaneously in- intermittent peritoneal dialysis, and 10 on conservative
volves both the sympathetic and parasympathetic path- treatment [26]. The largest decrease in power from con-
ways [22]. Therefore, spectral analysis of heart rate varia- trol to uremics, as a whole group, was observed in the mid
tions may permit unexpected insight into understanding (0.1 to 0.2 Hz) and respiratory (0.2 to 0.3 Hz) frequency
ranges, indicating a preeminent vagal depression or mostthe diseases of the autonomic nervous system.
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Table 2. Total variance and spectral components normalized by total variance in 30 chronic uremic patients
Controls Total uremics Uremics Uremics
(a) (b) without AN (c) with AN (d) Significance
Total variance ms2 18086270 5636123 5886151 549 6177 a vs. b, P , 0.00003
a vs. c, P , 0.004
a vs. d, P , 0.0005
c vs. d, NS
LF during lying (nu) 54 66 44 65 5368 39 67 NS
HF during lying (nu) 2364 2664 2867 2565 NS
LF during standing (nu) 7264 5266 56610 5068 a vs. b, P , 0.03
a vs. c, NS
a vs. d, P , 0.02
c vs. d, NS
HF during standing (nu) 15 62 16 63 1766 16 63 NS
Values are expressed as the mean 6 SEM. Abbreviations are: AN, autonomic neuropathy; LF, low-frequency band; HF, high-frequency band; nu, normalized
units; NS, not significant.
likely a dysfunction in both sympathetic and parasympa- a good assessment of sympathetic-parasympathetic car-
thetic tone. Particularly, a similar depression in auto- diovascular modulation between controls and the two
nomic control was demonstrated in hemodialysis and subgroups of uremic patients. More interestingly, the
peritoneal dialysis patients, whereas patients who as yet significant reduction of LF value in the supine uremic
were not undergoing dialysis showed a lesser degree AN group compared with normal controls suggests the
of depression. In another study, six uremic patients on presence of an early sympathetic involvement that tradi-
chronic intermittent hemodialysis exhibited reduced tional autonomic tests were unable to detect.
blood pressure and heart rate short-term variabilities, However, it has been reported that atropine in humans
with a dramatic reduction in the amplitude of the 0.1 reduces both 0.3 and 0.1 Hz spectral heart rate compo-
Hz component of systolic and diastolic blood pressure nents [29, 30], which indicates that parasympathetic mod-
spectra, reflecting a sympathetic neuropathy [27]. Dial- ulation is involved in the generation of both these spec-
ysis did not produce any consistent immediate improve- tral powers and that, at least in a number of conditions,
ment in the amplitudes. The findings reported by Muna- the 0.1 Hz component does not specifically reflect the
kata et al suggested that the decreased mid-frequency sympathetic cardiac drive. In light of such evidence, the
band of blood pressure could be attributed to low sensi- current opinion of an early and more frequent parasym-
tivity of the vasculature to sympathetic stimuli, and that pathetic damage in chronic uremic patients on hemodial-
the autonomic modulation of linear blood pressure/R-R ysis has to be modified in favor of a more widespread
interval relationships is frequency dependent [28]. Very autonomic dysfunction involving both the sympathetic
recently, in an investigation of 278 patients with end- and parasympathetic pathways.
stage renal disease of different causes and on different At rest, the HF component, that is, the spectral index
types of treatment, who were awaiting kidney transplanta-
of vagal activity, was similar in normal controls and ure-
tion, frequency domain measurements performed in 21
mic patients, suggesting an unchanged sympathovagalpatients more sensitively identified those with autonomic
balance in baseline conditions. However, the responsedysregulation than the traditional autonomic tests [8].
to standing was significantly altered in uremic patients,In the current study, we investigated 30 uremic pa-
with a clear difference between the two subgroups oftients on chronic hemodialysis and found that, in accor-
patients. Moreover, the LF/HF ratio, considered a gooddance with previous reports [3], 53% of the patients had
indicator of sympathovagal balance [21], did not signifi-a definite parasympathetic dysfunction that was isolated
cantly change in our patients in either the supine orin 40% and combined with a sympathetic damage in
standing position.13%, and 37% had a borderline parasympathetic dam-
In conclusion, our findings support the ability of theage. Nobody presented an isolated dysfunction of the
PSA of heart rate variability to evidence the occurrencesympathetic nervous system. When multivariate analysis
of alterations in cardiovascular autonomic activity inwas applied, 19 patients (63%) were identified as having
chronic uremics. The PSA technique may represent aa moderate-to-severe AN and the rest being with a nor-
complementary approach to traditional autonomic tests,mal autonomic nervous system function. Among the
providing a more accurate investigation of natural his-symptoms suggestive of autonomic dysfunction, only im-
tory of the disease and, most likely, response to therapeu-potence in males was significantly associated with test-
tic strategies. The possible clinical usefulness of PSA ofproven AN.
The results of the heart rate PSA have demonstrated heart rate variability as a tool for the early detection of
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15. Solders G, Wilczek H, Gunnarsson R, Tyden G, Persson A,subjects at increased risk of relevant autonomic failure
Groth CG: Effects of combined pancreatic and renal transplanta-
needs further study. tion on diabetic neuropathy: A two-year follow-up study. Lancet
2:1232–1234, 1987
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